Ciencia

Vacuna contra covid-19 probada en Estados Unidos genera respuesta inmune

Producto fue bien tolerado y generó una actividad de anticuerpos neutralizantes en 45 adultos sanos que se sometieron a prueba

A nurse (R) draws blood from Professor Francois Venter (L) before receiving the experimental vaccine for COVID-19 coronavirus at the Respiratory & Meningeal Pathogens Research Unit (RMPRU) at Chris Hani Baragwanath Hospital in Soweto on July 14, 2020. - Six senior clinicians in the Faculty of Health Sciences at Wits University have volunteered to participate in South Africa�s first COVID-19 vaccine trial. (Photo by Luca Sola / AFP)
A nurse (R) draws blood from Professor Francois Venter (L) before receiving the experimental vaccine for COVID-19 coronavirus at the Respiratory & Meningeal Pathogens Research Unit (RMPRU) at Chris Hani Baragwanath Hospital in Soweto on July 14, 2020. - Six senior clinicians in the Faculty of Health Sciences at Wits University have volunteered to participate in South Africa�s first COVID-19 vaccine trial. (Photo by Luca Sola / AFP) LUCA SOLA
‌
‌

‌

‌
‌

‌

‌